SUSTAINED RELEASE FORMULATION FOR TACROLIMUS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110281906A1
SERIAL NO

13195889

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A sustained release pharmaceutical composition for tacrolimus, comprising a solid dispersion containing tacrolimus or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a dissolution rate of tacrolimus after 4 hours from the beginning of a dissolution test is less than 35%, is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTELLAS PHARMA INC5-1 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO 103-8411

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ishii, Takuya Tokyo, JP 147 1708
Kojima, Hiroyuki Tokyo, JP 230 2751
Kondo, Hiromu Tokyo, JP 11 62
Taketani, Yuko Tokyo, JP 5 21
Yoshihara, Keiichi Tokyo, JP 18 211

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation